malondialdehyde has been researched along with mitoxantrone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorr, RT; Shipp, NG | 1 |
| Arnaiz, SL; Llesuy, SF | 1 |
| Adamczyk-Sowa, M; Labuz-Roszak, B; Pierzchala, K; Polaniak, R; Sowa, P | 1 |
| Adamczyk-Sowa, M; Hartel, M; Kukla, M; Pierzchala, K; Polaniak, R; Sowa, P | 1 |
1 trial(s) available for malondialdehyde and mitoxantrone
| Article | Year |
|---|---|
Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
Topics: Adjuvants, Immunologic; Adult; Antioxidants; Dietary Supplements; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Male; Malondialdehyde; Melatonin; Middle Aged; Mitoxantrone; Multiple Sclerosis; Neuropsychological Tests; Peptides; Quality of Life; Severity of Illness Index; Superoxide Dismutase; Young Adult | 2014 |
3 other study(ies) available for malondialdehyde and mitoxantrone
| Article | Year |
|---|---|
Biochemical effects and toxicity of mitoxantrone in cultured heart cells.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Heart; Lipid Peroxidation; Malondialdehyde; Mitoxantrone; Myocardium; Razoxane | 1991 |
Hepatotoxicity of mitoxantrone and doxorubicin.
Topics: Animals; Antioxidants; Catalase; Doxorubicin; Female; Glutathione; Glutathione Peroxidase; Lipid Peroxides; Liver; Malondialdehyde; Mice; Mitoxantrone; Superoxide Dismutase; Vitamin A | 1990 |
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Biomarkers; Catalase; Enzymes; Glutathione Peroxidase; Humans; Lipid Peroxidation; Malondialdehyde; Mitoxantrone; Multiple Sclerosis; Oxidative Stress; Superoxide Dismutase; Time Factors; Treatment Outcome | 2012 |